MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$167,292K
Accounts payable and
accrued expenses
$34,104K
Stock-based compensation
$28,719K
Accrued interest on
revenue interest...
$24,333K
Prepaid expenses and
other current assets
-$5,513K
Other
-$5,205K
Accrued
payment-in-kind interest on debt
$4,664K
Amortization of debt discount
$3,014K
Depreciation and
amortization
$633K
Inventory reserve
$280K
Operating right-of-use
assets and lease...
$222K
Accrued interest
$121K
Proceeds from issuance of
common stock from...
$1,638K
Net cash used in
operating activities
-$166,775K
Net cash (used in)
provided by financing...
-$288K
Net cash used in
investing activities
-$229K
Canceled cashflow
$106,808K
Canceled cashflow
$1,638K
Net loss
-$221,247K
Payment of employee tax
obligations related to...
-$1,926K
Cash paid for
property and equipment
$229K
Accounts receivable, net
$39,331K
Inventory
$11,781K
Other long-term
assets
$1,224K
Back
Back
Cash Flow
source: myfinsight.com
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)